The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is live webcast every Thursday at 12:00pm Eastern Time starting in October through June. All webcasts will be available for on-demand viewing immediately following the live broadcast. CME credit will be available for 24 hours following the start of each webcast.
Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.
Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hivgrandrounds for easy access.
This program has been designed for Family Medicine, Neurology, Obstetrics and Gynecology, Psychiatry, Internal Medicine, Internal Medicine - Infectious Disease.
HIV Grand Rounds is supported by independent educational grants from ViiV Healthcare, Janssen Therapeutics, Gilead Sciences, Inc. and Merck & Co.
After completing this activity, participants should be better able to:
After completing this activity, participants should be better able to:
Ian Frank, MD
Katherine Bar, MD
Florence Momplaisir, MD, MSHP, FACP |
The Next Presentation of HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania will be:
Presented live at 12:00 PM ET, weekly on Thursdays and anytime On-Demand
If CME credit is desired for any of the live sessions, proceed to https://upenn.cloud-cme.com to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit.
January 25, 2024 The Top Ten Publications in HIV Medicine in 2023 Ian Frank, MD February 1, 2024 Pharmacy-Based Approaches to Improving HIV and Substance Use Related Harms in High-Risk Communities Natalie Crawford, PhD February 8, 2024 Improving the Use and Effectiveness of Treatments for Tobacco Use among People with HIV Robert Schnoll, PhD February 22, 2024 Meeting you where you’re at: Innovating the delivery of HIV self-testing and PrEP care in Philadelphia Cedric Bien-Gund, MD February 29, 2024 Implementation Science to End the HIV Epidemic: How rapid, how relevant, & how rigorous? Sheree Schwartz, PhD March 14, 2024 A case-based tour through treating Non-tuberculous Mycobacteria infections Peter Liu, MD March 28, 2024 Impact of antiretrovirals in pregnancy: a holistic view Shahin Lockman, MD April 4, 2024 Highlights from CROI 2024, Part II: Prevention and Coinfections Ian Frank, MD Click HERE to View On-Demand Program April 11, 2024 Systems Vaccinology Bali Pulendran, PhD April 18, 2024 Understanding suicide risk among people with HIV: Intervention Opportunities Lily A. Brown, PhD April 25, 2024 Sexually Transmitted Infections in Vulnerable Populations Christina Muzny, MD May 9, 2024 Development of Highly Networked T cell Vaccines for HIV Gaurav Gaiha, MD, DPhil May 16, 2024 Innovations in HIV Prevention, Treatment, and Comorbidity Management: Clinical Insights and Cases Antonio E. Urbina, MD May 23, 2024 bnAbs for HIV Prevention - Do They Have a Role as Long-Acting PrEP Ian Frank, MD May 30, 2024 How Do Health Insurance Expansions Affect Disparities in HIV Prevention and Treatment? Aparna Soni, PhD June 13, 2024
Primary Cardiovascular Prevention for People with HIV in 2024: Implications of the REPRIEVE Trial Steven Grinspoon, MD September 12, 2024
HIV Genetic Blueprint: from the clinic to public health Ann M. Dennis, MD, MS September 19, 2024
Off Target for 2030: The Challenge of HIV Incidence Chris Beyrer, MD, MPH September 26, 2024
Highlights from the International AIDS Society Conference, Munich 2024
Renslow Sherer, MD October 3, 2024
Covid-19: Lessons from the Past Four Years
Paul Offit, MD
TO VIEW PREVIOUS HIV GRAND ROUNDS PLEASE SEE BELOW: |
You will need Internet to participate in this activity.
In support of improving patient care, this activity has been planned and implemented by Penn Medicine and ViralEd. Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses/Pharmacists: This activity is not approved for nursing or pharmacy contact hours
PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.
It is policy at Penn Medicine Office of Continuing Medical and Interprofessional Education for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity. For this purpose, we consider relationships of the person involved to include financial relationships of a spouse or partner.
The intent of this policy is to ensure that Penn CME/CE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of Continuing Medical and Interprofessional Education (CME and IPCE) have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity. Any peer reviewer with a potential conflict of interest will recuse themselves from the peer review process.
The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
Florence Momplaisir, MD (Program Co-Director) Planning Committee Members:
Presenter: Paul Offit, MD
|
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
Ian Frank, MD (Program Co-director)
|
The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside DA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.